From a clinical standpoint, the detailed genomic characterisation of P1 established the pathogenic role of homozygous IFNAR1 variants while concomitantly excluding DOCK8 deficiency. The gene discussed is DOCK8; the disease is hyperinsulinemic hypoglycemia, familial, 4.